Bloodstream infections are an improbable cause of positive serum (1,3)-β-D-Glucan in hematology patients

Clinical and Vaccine Immunology

Volumn 21, Issue 9, 2014, Pages 1357-1359

  Furfaro, E ^a   Mikulska, M ^a   Del Bono, V ^a   Guolo, F ^a   Minetto, P ^a   Gobbi, M ^a   Ghiso, A ^a   Bacigalupo, A ^a   Viscoli, C ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1,3 GLUCAN; BETA GLUCAN; BETA-1,3-D-GLUCAN;

ARTICLE; ASSAY; BACTEREMIA; BLOOD CULTURE; BLOOD SAMPLING; BLOODSTREAM INFECTION; FALSE POSITIVE RESULT; HEMATOLOGIC MALIGNANCY; HUMAN; INVASIVE ASPERGILLOSIS; INVASIVE FUNGAL DISEASE; MAJOR CLINICAL STUDY; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; BLOOD; CHEMISTRY; COMPLICATION; HEMATOLOGIC DISEASE; INVASIVE PULMONARY ASPERGILLOSIS; LABORATORY DIAGNOSIS; PATHOLOGY; SERUM;

BETA-GLUCANS; FALSE POSITIVE REACTIONS; HEMATOLOGIC NEOPLASMS; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS; SERUM;

EID: 84916877187     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00214-14     Document Type: Article

References (17)

1. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE, European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group, National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 46:1813-1821. http://dx.doi.org/10.1086/588660.
2. Kawazu M, Kanda Y, Nannya Y, Aoki K, Kurokawa M, Chiba S, Motokura T, Hirai H, Ogawa S. 2004. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1→3)-β-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J. Clin. Microbiol. 42:2733-2741. http://dx.doi.org/10.1128/JCM.42.6.2733-2741.2004. (Pubitemid 38747529)
3. Odabasi Z, Mattiuzzi G, Estey E, Kantarjian H, Saeki F, Ridge RJ, Ketchum PA, Finkelman MA, Rex JH, Ostrosky-Zeichner L. 2004. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin. Infect. Dis. 39:199-205. http://dx.doi.org/10. 1086/421944. (Pubitemid 38971490)
4. Mennink-Kersten MA, Ruegebrink D, Verweij PE. 2008. Pseudomonas aeruginosa as a cause of 1,3-beta-D-glucan assay reactivity. Clin. Infect. Dis. 46:1930-1931. http://dx.doi.org/10.1086/588563.
5. Stone BA, Clarke AE. 1992. Chemistry and biology of (1→3)beta-D- glucans. La Trobe University Press, Melbourne, Australia.
6. Digby J, Kalbfleisch J, Glenn A, Larsen A, Browder W, Williams D. 2003. Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin. Diagn. Lab. Immunol. 10:882-885. http://dx.doi.org/10.1128/CDLI.10.5.882-885.2003. (Pubitemid 37129504)
7. Pickering JW, Sant HW, Bowles CA, Roberts WL, Woods GL. 2005. Evaluation of a (1-3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J. Clin. Microbiol. 43:5957-5962. http://dx.doi.org/10.1128/JCM.43.12.5957-5962. 2005. (Pubitemid 43100644)
8. Racil Z, Kocmanova I, Lengerova M, Weinbergerova B, Buresova Toskova M, Winterova J, Timilsina S, Rodriguez I, Mayer J. 2010. Difficulties in using 1-3-{beta}-D-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies- high frequency of false-positive results and their analysis. J. Med. Microbiol. 59:1016-1022. http://dx.doi.org/10.1099/jmm.0.019299-0.
9. Albert O, Toubas D, Strady C, Cousson J, Delmas C, Vernet V, Villena I. 2011. Reactivity of (1→3)-β-D-glucan assay in bacterial bloodstream infections. Eur. J. Clin. Microbiol. Infect. Dis. 30:1453-1460. http://dx.doi.org/10.1007/s10096-011-1244-8.
10. Koya J, Nannya Y, Kobayashi H, Okugawa S, Moriya K, Kurokawa M. 2013. Simultaneous increase in 1,3-β-D-glucan and procalcitonin levels in Pseudomonas aeruginosa infection. J. Infect. 67:164-166. http://dx.doi.org/10. 1016/j.jinf.2013.03.017.
11. Racil Z, Kocmanova I, Toskova M, Winterova J, Lengerova M, Timilsina S, Mayer J. 2013. Reactivity of the 1,3-β-D-glucan assay during bacteraemia: limited evidence from a prospective study. Mycoses 56:101-104. http://dx.doi.org/10.1111/j.1439-0507.2012.02210.x.
12. Metan G, Koc AN, Aǧkuş Ç Kaynar LG, Alp E, Eser B. 2012. Can bacteraemia lead to false positive results in 1,3-beta-D-glucan test? Analysis of 83 bacteraemia episodes in high-risk patients for invasive fungal infections. Rev. Iberoam. Micol. 29:169-171. http://dx.doi.org/10.1016/j.riam. 2011.07.003.
13. Kelaher A. 2006. Two non-invasive diagnostic tools for invasive aspergilosis: (1-3)-beta-D-glucan and the galactomannan assay. Clin. Lab. Sci. 19:222-224.
14. Pazos C, Ponton J, Del Palacio A. 2005. Contribution of (1-3)-β-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J. Clin. Microbiol. 43:299-305. http://dx.doi.org/10.1128/JCM.43.1.299-305.2005. (Pubitemid 40096315)
15. Lamoth F, Cruciani M, Mengoli C, Castagnola E, Lortholary O, Richardson M, Marchetti O, Third European Conference on Infections in Leukemia (ECIL-3). 2012. β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3). Clin. Infect. Dis. 54:633-643. http://dx.doi.org/10.1093/ cid/cir897.
16. Ellis M, Al-Ramadi B, Finkelman M, Hedstrom U, Kristensen J, Ali-Zadeh H, Klingspor L. 2008. Assessment of the clinical utility of serial beta-D-glucan concentrations in patients with persistent neutropenic fever. J. Med. Microbiol. 57:287-295. http://dx.doi.org/10.1099/jmm.0.47479-0. (Pubitemid 351358531)
17. Del Bono V, Delfino E, Furfaro E, Mikulska M, Nicco E, Bruzzi P, Mularoni A, Bassetti M, Viscoli C. 2011. Clinical performance of the (1,3)-β-D-glucan assay in early diagnosis of nosocomial Candida blood-stream infections. Clin. Vaccine Immunol. 18:2113-2117. http://dx.doi.org/10.1128/CVI.05408-11.